{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:52:21Z","timestamp":1773885141265,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R43HL169066"],"award-info":[{"award-number":["R43HL169066"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL152280"],"award-info":[{"award-number":["R01HL152280"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xjon.2025.09.019","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:23:24Z","timestamp":1758619404000},"page":"250-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Administration of a novel reprogramming formula improves cardiac function and decreases cardiac fibrosis in a myocardial infarction model"],"prefix":"10.1016","volume":"28","author":[{"given":"Megumi","family":"Mathison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saliha S.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya","family":"Lackan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M.A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-0573","authenticated-orcid":false,"given":"Todd K.","family":"Rosengart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xjon.2025.09.019_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.xjon.2025.09.019_bib2","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7400","key":"10.1016\/j.xjon.2025.09.019_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"issue":"7400","key":"10.1016\/j.xjon.2025.09.019_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xjon.2025.09.019_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtcvs.2018.03.162","article-title":"p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells","volume":"156","author":"Patel","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.xjon.2025.09.019_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003922","article-title":"MiR-590 promotes transdifferentiation of porcine and human fibroblasts toward a cardiomyocyte-like fate by directly repressing specificity protein 1","volume":"5","author":"Singh","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.xjon.2025.09.019_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015686","article-title":"Enhanced generation of induced cardiomyocytes using a small-molecule cocktail to overcome barriers to cardiac cellular reprogramming","volume":"9","author":"Singh","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"566","key":"10.1016\/j.xjon.2025.09.019_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay7856","article-title":"Down-regulation of Beclin1 promotes direct cardiac reprogramming","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.xjon.2025.09.019_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.stemcr.2017.01.025","article-title":"Notch inhibition enhances cardiac reprogramming by increasing MEF2C transcriptional activity","volume":"8","author":"Abad","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"6290","key":"10.1016\/j.xjon.2025.09.019_bib10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.aaf1502","article-title":"Conversion of human fibroblasts into functional cardiomyocytes by small molecules","volume":"352","author":"Cao","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xjon.2025.09.019_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep40285","article-title":"Core transcription factors, microRNAs, and small molecules drive transdifferentiation of human fibroblasts towards the cardiac cell lineage","volume":"7","author":"Christoforou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjon.2025.09.019_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13619-015-0024-9","article-title":"Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency","volume":"4","author":"Ebrahimi","year":"2015","journal-title":"Cell Regen"},{"issue":"10","key":"10.1016\/j.xjon.2025.09.019_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s13238-017-0402-x","article-title":"Molecular barriers to direct cardiac reprogramming","volume":"8","author":"Vaseghi","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.xjon.2025.09.019_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lfs.2017.04.013","article-title":"Boosters and barriers for direct cardiac reprogramming","volume":"178","author":"Talkhabi","year":"2017","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.xjon.2025.09.019_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02056-x","article-title":"Fibroblast transition to an endothelial \"trans\" state improves cell reprogramming efficiency","volume":"11","author":"Mathison","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xjon.2025.09.019_bib16","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1038\/s41598-022-15559-y","article-title":"p63 Silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation","volume":"12","author":"Pinnamaneni","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xjon.2025.09.019_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005652","article-title":"In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor","volume":"1","author":"Mathison","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.xjon.2025.09.019_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jtcvs.2016.09.041","article-title":"In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: implications for clinical myocardial regeneration","volume":"153","author":"Mathison","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.xjon.2025.09.019_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymthe.2003.09.014","article-title":"Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs","volume":"9","author":"Whitlock","year":"2004","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.xjon.2025.09.019_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014054","article-title":"Angiogenic gene therapy for refractory angina: results of the EXACT phase 2 trial","volume":"17","author":"Nakamura","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"issue":"621","key":"10.1016\/j.xjon.2025.09.019_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5758","article-title":"Importance of the pig as a human biomedical model","volume":"13","author":"Lunney","year":"2021","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.xjon.2025.09.019_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jtcvs.2017.06.035","article-title":"Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail","volume":"154","author":"Mathison","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.xjon.2025.09.019_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.107.744623","article-title":"Heterogeneity of left ventricular wall thickening mechanisms","volume":"118","author":"Cheng","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.xjon.2025.09.019_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cvr\/cvm101","article-title":"Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction","volume":"78","author":"Hassink","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.xjon.2025.09.019_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.750510","article-title":"Cardiomyocyte cellular phenotypes after myocardial infarction","volume":"8","author":"Lodrini","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.xjon.2025.09.019_bib26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.123.065880","article-title":"Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?","volume":"149","author":"Chen","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.xjon.2025.09.019_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/hum.2012.137","article-title":"Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease","volume":"24","author":"Rosengart","year":"2013","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.xjon.2025.09.019_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr Gene Ther"},{"issue":"1","key":"10.1016\/j.xjon.2025.09.019_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/10430340152712647","article-title":"Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions","volume":"13","author":"Crystal","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.xjon.2025.09.019_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jtcvs.2003.09.049","article-title":"Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation","volume":"127","author":"Retuerto","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.xjon.2025.09.019_bib31","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jtcvs.2014.03.033","article-title":"\u201cTriplet\u201d polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors","volume":"148","author":"Mathison","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.xjon.2025.09.019_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xjon.2025.09.019_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156652311795684740","article-title":"Current advances in retroviral gene therapy","volume":"11","author":"Yi","year":"2011","journal-title":"Curr Gene Ther"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273625003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273625003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:24:16Z","timestamp":1773865456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666273625003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S2666273625003134"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2025.09.019","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of a novel reprogramming formula improves cardiac function and decreases cardiac fibrosis in a myocardial infarction model","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2025.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}